DENVER, Aug. 28, 2026 (GLOBE NEWSWIRE) -- For NeOnc Technologies Holdings (NASDAQ: NTHI), the most i

DENVER, Aug. 26, 2026 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings (NASDAQ: NTHI) has reached a p

DENVER, Aug. 18, 2026 (GLOBE NEWSWIRE) -- (247marketnews.com) -- NeOnc Technologies Holdings (NASDAQ

DENVER, Aug. 17, 2026 (GLOBE NEWSWIRE) -- Here are today's catalysts reshaping the market narrative.

NeOnc's (NASDAQ:NTHI) Phase 2a results for NEO100 in recurrent IDH1-mutant high-grade glioma make it

Gainers MDxHealth (NASDAQ:MDXH) stock moved upwards by 120.8% to $1.02 during Friday's regular

Dallas, Texas--(Newsfile Corp. - August 13, 2026) - NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI)

DENVER, Aug. 13, 2026 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings' (NASDAQ: NTHI) August 12 head

Gainers BioVie (NASDAQ:BIVI) shares increased by 39.4% to $1.77 during Wednesday's regular sess

DALLAS, Aug. 12, 2026 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings (NASDAQ: NTHI) has delivered t

Phase 2a results showed 48.9% six-month progression-free survival versus a 20% historical benchmark,

— Study met its primary endpoint: six-month progression-free survival of 48.9% versus a pre-specifie

Company to request a Type B meeting with the FDA to align on a registrational path in a setting with

Houston, Texas--(Newsfile Corp. - August 11, 2026) - NeOnc Technologies Holdings (NASDAQ: NTHI) is s

Gainers Mereo BioPharma Group (NASDAQ:MREO) stock increased by 21.7% to $0.33 during Tuesday's

NeOnc Technologies (NASDAQ:NTHI) reported quarterly losses of $(0.58) per share which missed the ana

NeOnc (Nasdaq: NTHI) will host an investor conference call and webcast on Wednesday, August 12, 2026

CALABASAS, Calif., July 27, 2026 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (Nasdaq: NTHI

Gainers GlucoTrack (NASDAQ:GCTK) stock moved upwards by 28.6% to $0.64 during Thursday's after-

NeOnc Technologies Holdings, Inc. (NASDAQ:NTHI) ("NeOnc" or the "Company"), a clinic

CALABASAS, Calif., July 15, 2026 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI

Three emerging biotechnology companies, Can-Fite (NYSE: CANF), NeOnc (NASDAQ: NTHI), and PMGC (NASDA

DENVER, June 24, 2026 (GLOBE NEWSWIRE) -- ( 247marketnews.com ) -- NeOnc Technologies Holdings (NASD

NeOnc Technologies Holdings, Inc. (Nasdaq: NTHI) ("NeOnc" or the "Company"), a clini

Authorization covers all three NEO100 programs across adult Phase 1 through Phase 2, plus pediatric

International Regulatory Validation Has Preceded Several Recent FDA Success Stories, Though Signific

NeOnc Technologies Holdings (NASDAQ:NTHI) is rapidly emerging as a development-stage neuro-oncology

DALLAS, June 17, 2026 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings (NASDAQ: NTHI) is rapidly emer

Clearance enables Phase 2 evaluation of NEO212, the Company's oral perillyl alcohol-temozolomide

The transactions contemplated by the Purchase Agreement are expected to close upon the satisfaction

BTIG analyst Thomas Shrader reiterates NeOnc Technologies Hldgs (NASDAQ:NTHI) with a Buy and main

Alliance Global Partners analyst Matthew Venezia initiates coverage on NeOnc Technologies Hldgs (

Maxim Group analyst Jason McCarthy initiates coverage on NeOnc Technologies Hldgs (NASDAQ:NTHI) w

NeOnc Technologies (NASDAQ:NTHI) reported quarterly losses of $(0.38) per share which missed the ana

NeOnc Technologies Holdings, Inc. (NASDAQ:NTHI) ("NeOnc" or the "Company"), a clinic

Top Wall Street analysts changed outlook on top names. See analyst ratings page for complete view. W

BTIG analyst Thomas Shrader initiates coverage on NeOnc Technologies Hldgs (NASDAQ:NTHI) with a B

Entry into a Material Definitive Agreement. At The Market Offering On April 10, 2026, the Company en

 $300,000,000Common StockPreferred StockDebt SecuritiesWarrantsRightsUnitsFrom time to time, we may

NeOnc Technologies (NASDAQ:NTHI) reported quarterly losses of $(0.72) per share which missed the ana

NeOnc Technologies Holdings, Inc. (NASDAQ:NTHI) ("NeOnc" or the "Company"), a multi-

NeOnc Technologies Holdings, Inc. (NASDAQ:NTHI) ("NeOnc" or the "Company"), a multi-

NeOnc Technologies Holdings, Inc. (Nasdaq: NTHI) ("NeOnc" or the "Company"), a multi

Updated results demonstrate that treatment with intranasally delivered NEO100 has resulted in signif

NeOnc Technologies Holdings, Inc. (NASDAQ:NTHI) ("NeOnc" or the "Company"), a multi-